INtRON Biotechnology Financials
| 048530 Stock | KRW 5,550 50.00 0.89% |
INtRON |
Understanding current and past INtRON Biotechnology Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of INtRON Biotechnology's financial statements are interrelated, with each one affecting the others. For example, an increase in INtRON Biotechnology's assets may result in an increase in income on the income statement.
Please note, the presentation of INtRON Biotechnology's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, INtRON Biotechnology's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of INtRON Biotechnology's management manipulating its earnings.
INtRON Biotechnology Stock Summary
INtRON Biotechnology competes with Samsung Electronics, Samsung Electronics, LG Energy, SK Hynix, and Samsung Biologics. iNtRON Biotechnology, Inc., a biotechnology company, develops bacterial bio-drugs for the treatment of infectious diseases. In addition, the company develops drugs targeting functional moieties, including axakacin, pterostilbene, methylated flavonoid, etc. for use in silver and brain industries. iNtRON Biotechnology, Inc. was founded in 1999 and is headquartered in Seongnam, South Korea. iNtRON Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7048530000 |
| Business Address | 137, Sagimakgol-ro, Seongnam-si, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.intron.co.kr |
| Phone | 82 3 1739 5678 |
| Currency | KRW - South Korean Won |
You should never invest in INtRON Biotechnology without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of INtRON Stock, because this is throwing your money away. Analyzing the key information contained in INtRON Biotechnology's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
INtRON Biotechnology Key Financial Ratios
INtRON Biotechnology's financial ratios allow both analysts and investors to convert raw data from INtRON Biotechnology's financial statements into concise, actionable information that can be used to evaluate the performance of INtRON Biotechnology over time and compare it to other companies across industries.| Return On Equity | 11.16 | |||
| Return On Asset | 0.0519 | |||
| Target Price | 16400.0 | |||
| Number Of Employees | 93 | |||
| Beta | 0.45 |
INtRON Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining INtRON Biotechnology's current stock value. Our valuation model uses many indicators to compare INtRON Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across INtRON Biotechnology competition to find correlations between indicators driving INtRON Biotechnology's intrinsic value. More Info.iNtRON Biotechnology is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The ratio of Return On Equity to Return On Asset for iNtRON Biotechnology is about 215.06 . Comparative valuation analysis is a catch-all model that can be used if you cannot value INtRON Biotechnology by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for INtRON Biotechnology's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.iNtRON Biotechnology Systematic Risk
INtRON Biotechnology's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. INtRON Biotechnology volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on iNtRON Biotechnology correlated with the market. If Beta is less than 0 INtRON Biotechnology generally moves in the opposite direction as compared to the market. If INtRON Biotechnology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one iNtRON Biotechnology is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of INtRON Biotechnology is generally in the same direction as the market. If Beta > 1 INtRON Biotechnology moves generally in the same direction as, but more than the movement of the benchmark.
INtRON Biotechnology Thematic Clasifications
iNtRON Biotechnology is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas
| Biotech | View |
INtRON Biotechnology November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of INtRON Biotechnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of iNtRON Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of iNtRON Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing INtRON Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build INtRON Biotechnology's daily price indicators and compare them against related drivers.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 10.61 | |||
| Value At Risk | (2.75) | |||
| Potential Upside | 2.84 |
Complementary Tools for INtRON Stock analysis
When running INtRON Biotechnology's price analysis, check to measure INtRON Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INtRON Biotechnology is operating at the current time. Most of INtRON Biotechnology's value examination focuses on studying past and present price action to predict the probability of INtRON Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INtRON Biotechnology's price. Additionally, you may evaluate how the addition of INtRON Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges |